Harvard Bioscience, Inc. Announces Resignation of Yong Sun as Vice President and General Manager of Physiology, Cell and Molecular Instruments, Effective as of January 4, 2019
December 17, 2018 at 08:31 am EST
Share
On December 14, 2018, Yong Sun submitted his resignation from all positions held with Harvard Bioscience, Inc. including his position as Vice President and General Manager of Physiology, Cell and Molecular Instruments, in order to pursue other interests. Mr. Sun's resignation will be effective as of January 4, 2019.
Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development. Its products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. The CMT product family is primarily composed of products supporting research related to molecular, cellular, organ and organoid technologies. The Preclinical product family includes products that support the preclinical research and testing phase for drug development, and in particular, testing related to data collection and analysis for safety and regulatory compliance.
Harvard Bioscience, Inc. Announces Resignation of Yong Sun as Vice President and General Manager of Physiology, Cell and Molecular Instruments, Effective as of January 4, 2019
HARVARD BIOSCIENCE, INC. 
